Diabetic neuropathy and loss of protective sensation (LOPS) are responsible for $42 million, or 24% of all costs with 60% of all non-traumatic amputations occurring in diabetic patients. For those with diabetic foot ulcerations and/or lower extremity amputations, their five-year mortality rate is higher than that from prostate cancer, breast cancer, colon cancer and Hodgkin’s disease (ADA 2011).

With a simple and effective test available, these statistics are unacceptable. In fact, studies have shown that amputations are preventable 45%-85% of the time with proper care and attention. Our mission is to create a high-quality medical device that allows patients and clinicians to perform a simple test diagnosing loss of protective sensation (LOPS), and preventing diabetic foot ulcerations and amputations (CDC 2011). To this end, we hope to help patients receive proactive diabetes foot care for a healthy and sustainable future.

Monofilament Test Demonstration - Video